Skip to main content
Top
Published in: Journal of Nuclear Cardiology 3/2017

01-06-2017 | Debate Article

Interpreting the change in left ventricular ejection fraction during pharmacological coronary vasodilation: Proceed with caution!

Author: Steven Port, MD

Published in: Journal of Nuclear Cardiology | Issue 3/2017

Login to get access

Excerpt

The left ventricular ejection fraction (LVEF) is a major determinant of outcome in patients with coronary artery disease. No matter how LVEF is measured, whether by direct contrast ventriculography, echocardiography, radionuclide angiography, gated radionuclide myocardial perfusion imaging(MPI), gated magnetic resonance imaging (MRI), or X-ray computed tomographic imaging, that relationship persists. That said, LVEF has typically been measured at rest using most of the aforementioned modalities. But when it comes to LVEF during interventions, the “playing field” becomes a lot less level. Using poetic license to lump all interventions as stress, the variations of stress LVEF include measurements during upright exercise or supine exercise (radionuclide angiography), immediately (within 60 seconds) post-exercise (Echo), delayed (>15 minutes) post-exercise (gated SPECT MPI), during a continuous intravenous dobutamine infusion (Echo and MRI), and either during (MRI) or >15 minutes following (gated SPECT MPI) an adenosine infusion or following an intravenous regadenoson injection or an intravenous dipyridamole infusion. …
Literature
1.
go back to reference Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ. Initial clinical experience with Regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;46:2069-75.CrossRefPubMed Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ. Initial clinical experience with Regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;46:2069-75.CrossRefPubMed
2.
go back to reference Nair PK, Marroquin OC, Mulukutla RS, Khandhar S, Gulati V, Schindler JT, Lee JS. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv. 2011;4:1085-92.CrossRefPubMed Nair PK, Marroquin OC, Mulukutla RS, Khandhar S, Gulati V, Schindler JT, Lee JS. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv. 2011;4:1085-92.CrossRefPubMed
3.
go back to reference Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang WJ. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. Nucl Cardiol. 2007;14:645-58.CrossRef Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang WJ. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. Nucl Cardiol. 2007;14:645-58.CrossRef
4.
go back to reference Dhalla A, Wong MY, Wang WQ, Biagionni I, Belardinelli L. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharmacol Exp Ther. 2006;316:695-702.CrossRefPubMed Dhalla A, Wong MY, Wang WQ, Biagionni I, Belardinelli L. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharmacol Exp Ther. 2006;316:695-702.CrossRefPubMed
5.
go back to reference Abel RM. Reis RI effects of coronary blood flow and perfusion pressure on left ventricular contractility in dogs. Circ Res. 1970;27:961-71.CrossRefPubMed Abel RM. Reis RI effects of coronary blood flow and perfusion pressure on left ventricular contractility in dogs. Circ Res. 1970;27:961-71.CrossRefPubMed
6.
go back to reference Christensen CW, Rosen LB, Gal RA, Haseeb M, Lassar TA, Port SC, Christensen C. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function and myocardial metabolism. Circ. 1991;83:294-303.CrossRef Christensen CW, Rosen LB, Gal RA, Haseeb M, Lassar TA, Port SC, Christensen C. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function and myocardial metabolism. Circ. 1991;83:294-303.CrossRef
7.
go back to reference Port S, Cobb FR, Coleman RE, Jones RH. Effects of age on the response of the left ventricular ejection fraction to exercise. NEJM. 1980;303:1133-7.CrossRefPubMed Port S, Cobb FR, Coleman RE, Jones RH. Effects of age on the response of the left ventricular ejection fraction to exercise. NEJM. 1980;303:1133-7.CrossRefPubMed
8.
go back to reference Fleg J, O’Connor F, Gerstenblith G, Becker LC, Clulow J, Schulman SP, Lakatta EG. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J App Physiol. 1995;78:890-900. Fleg J, O’Connor F, Gerstenblith G, Becker LC, Clulow J, Schulman SP, Lakatta EG. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J App Physiol. 1995;78:890-900.
9.
go back to reference Port S, McEwan P, Cobb FR, Jones RH. Influence of resting left ventricular function on the left ventricular response to exercise in patients with coronary artery disease. Circulation. 1981;63:856-63.CrossRefPubMed Port S, McEwan P, Cobb FR, Jones RH. Influence of resting left ventricular function on the left ventricular response to exercise in patients with coronary artery disease. Circulation. 1981;63:856-63.CrossRefPubMed
10.
go back to reference Foster C, Anholm JD, Dymond DS, Carpenter J, Pollock ML · Schmidt DH. Cardiology 1982;69: 24-230 1982 Foster C, Anholm JD, Dymond DS, Carpenter J, Pollock ML · Schmidt DH. Cardiology 1982;69: 24-230 1982
11.
go back to reference Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT Study. J Nucl Med. 2007;48:349-58.PubMed Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT Study. J Nucl Med. 2007;48:349-58.PubMed
12.
go back to reference Bravo PE, Chien D, Javadi M, Merril J, Bengel FM. Reference ranges for LVEF and LV volumes from electrocardiographically gated 82Rb cardiac PET/CT using commercially available software. J Nucl Med. 2010;51(6):898-905.CrossRefPubMed Bravo PE, Chien D, Javadi M, Merril J, Bengel FM. Reference ranges for LVEF and LV volumes from electrocardiographically gated 82Rb cardiac PET/CT using commercially available software. J Nucl Med. 2010;51(6):898-905.CrossRefPubMed
13.
go back to reference Lee K, Pryor DB, Pieper KS, Harrell FE Jr, Califf RM, Mark DB, Hlatky MA, Coleman RE, Cobb FR, Jones RH. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: A comparison with clinical and catheterization variables. Circulation. 1990;82:1705-17.CrossRefPubMed Lee K, Pryor DB, Pieper KS, Harrell FE Jr, Califf RM, Mark DB, Hlatky MA, Coleman RE, Cobb FR, Jones RH. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: A comparison with clinical and catheterization variables. Circulation. 1990;82:1705-17.CrossRefPubMed
14.
go back to reference Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. JACC. 1999;33:708-16.CrossRefPubMed Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. JACC. 1999;33:708-16.CrossRefPubMed
15.
go back to reference Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic values of cardiac magnetic resonance stress tests. Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769-76.CrossRefPubMed Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic values of cardiac magnetic resonance stress tests. Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769-76.CrossRefPubMed
16.
go back to reference Bodi V, Sanchis J, Lopez-Lereu MP. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174-9.CrossRefPubMed Bodi V, Sanchis J, Lopez-Lereu MP. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174-9.CrossRefPubMed
17.
go back to reference Hsiao E, Ali B, Blankstein R, Skali H, Ali T, Bruyere J Jr, Kwong RY, Di Carli MF, Dorbala S. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013;54(10):1748-54.CrossRefPubMedPubMedCentral Hsiao E, Ali B, Blankstein R, Skali H, Ali T, Bruyere J Jr, Kwong RY, Di Carli MF, Dorbala S. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013;54(10):1748-54.CrossRefPubMedPubMedCentral
18.
go back to reference Brown TL, Volokh L, Bengel FM. Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated (82) rubidium myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2008;35:336-42.CrossRefPubMed Brown TL, Volokh L, Bengel FM. Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated (82) rubidium myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2008;35:336-42.CrossRefPubMed
19.
go back to reference Van Tosh A, Votaw JR, Reichek N, Palestro CJ, Nichols KJ. The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated 82Rb PET myocardial perfusion imaging. J Nucl Cardiol. 2013;20(6):1060-8.CrossRefPubMedPubMedCentral Van Tosh A, Votaw JR, Reichek N, Palestro CJ, Nichols KJ. The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated 82Rb PET myocardial perfusion imaging. J Nucl Cardiol. 2013;20(6):1060-8.CrossRefPubMedPubMedCentral
20.
go back to reference Dorbala S, Hachamovitch R, Cunilova Z, Thomas D, Vangala D, Kwong R. DiCarli MF Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF JACC. Cardiovasc Imaging. 2009;2(7):846-54. Dorbala S, Hachamovitch R, Cunilova Z, Thomas D, Vangala D, Kwong R. DiCarli MF Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF JACC. Cardiovasc Imaging. 2009;2(7):846-54.
21.
go back to reference Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, Heller G. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15:745-53.CrossRefPubMed Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, Heller G. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15:745-53.CrossRefPubMed
Metadata
Title
Interpreting the change in left ventricular ejection fraction during pharmacological coronary vasodilation: Proceed with caution!
Author
Steven Port, MD
Publication date
01-06-2017
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 3/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-017-0837-8

Other articles of this Issue 3/2017

Journal of Nuclear Cardiology 3/2017 Go to the issue